C A McCarty1, M B Nanjan, H R Taylor. 1. Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Australia. cathy@cera.unimeb.edu.au
Abstract
AIM: To describe predictors of mortality in the 5 year follow up of the Melbourne Visual Impairment Project (VIP) cohort. METHODS: The Melbourne VIP was a population based study of the distribution and determinants of age related eye disease in a cluster random sample of Melbourne residents aged 40 years and older. Baseline examinations were conducted between 1992 and 1994. In 1997, 5 year follow up examinations of the original cohort commenced. Causes of death were obtained from the National Death Index for all reported deaths. RESULTS: Of the original 3271 participants, 231 (7.1%) were reported to have died in the intervening 5 years. Of the remaining 3040 participants eligible to return for follow up examinations, 2594 (85% of eligible) did participate, 51 (2%) had moved interstate or overseas, 83 (3%) could not be traced, and 312 (10%) refused to participate. Best corrected visual acuity <6/12 (OR=2.34) was associated with a significantly increased risk of mortality, as were increasing age (OR=1.09), male sex (OR=1.62), increased duration of cigarette smoking (OR=2.06 for smoking >30 years), increased duration of hypertension (OR=1.51 for duration >10 years), and arthritis (OR=1.42). CONCLUSIONS: Even mild visual impairment increases the risk of death more than twofold. Further research is needed to determine why decreased visual acuity is associated with increased risk of mortality.
AIM: To describe predictors of mortality in the 5 year follow up of the Melbourne Visual Impairment Project (VIP) cohort. METHODS: The Melbourne VIP was a population based study of the distribution and determinants of age related eye disease in a cluster random sample of Melbourne residents aged 40 years and older. Baseline examinations were conducted between 1992 and 1994. In 1997, 5 year follow up examinations of the original cohort commenced. Causes of death were obtained from the National Death Index for all reported deaths. RESULTS: Of the original 3271 participants, 231 (7.1%) were reported to have died in the intervening 5 years. Of the remaining 3040 participants eligible to return for follow up examinations, 2594 (85% of eligible) did participate, 51 (2%) had moved interstate or overseas, 83 (3%) could not be traced, and 312 (10%) refused to participate. Best corrected visual acuity <6/12 (OR=2.34) was associated with a significantly increased risk of mortality, as were increasing age (OR=1.09), male sex (OR=1.62), increased duration of cigarette smoking (OR=2.06 for smoking >30 years), increased duration of hypertension (OR=1.51 for duration >10 years), and arthritis (OR=1.42). CONCLUSIONS: Even mild visual impairment increases the risk of death more than twofold. Further research is needed to determine why decreased visual acuity is associated with increased risk of mortality.
Authors: W G Christen; R J Glynn; U A Ajani; D A Schaumberg; J E Manson; J E Buring; C H Hennekens Journal: Ophthalmic Epidemiol Date: 2000-06 Impact factor: 1.648
Authors: D Diane Zheng; Sharon L Christ; Byron L Lam; Kristopher L Arheart; Anat Galor; David J Lee Journal: Invest Ophthalmol Vis Sci Date: 2012-05-14 Impact factor: 4.799
Authors: Diana Fisher; Chuan-Ming Li; May S Chiu; Christa L Themann; Hannes Petersen; Friðbert Jónasson; Pálmi V Jónsson; Johanna Eyrun Sverrisdottir; Melissa Garcia; Tamara B Harris; Lenore J Launer; Gudny Eiriksdottir; Vilmundur Gudnason; Howard J Hoffman; Mary Frances Cotch Journal: Age Ageing Date: 2013-08-30 Impact factor: 10.668
Authors: Heather E Whitson; Deidra Ansah; Diane Whitaker; Guy Potter; Scott W Cousins; Heather MacDonald; Carl F Pieper; Lawrence Landerman; David C Steffens; Harvey J Cohen Journal: Arch Gerontol Geriatr Date: 2009-05-07 Impact factor: 3.250
Authors: Rohit Varma; Michelle Y Wang; Mei Ying-Lai; Jill Donofrio; Stanley P Azen Journal: Invest Ophthalmol Vis Sci Date: 2008-04-25 Impact factor: 4.799
Authors: Xinzhi Zhang; Mary Frances Cotch; Asel Ryskulova; Susan A Primo; Parvathy Nair; Chiu-Fang Chou; Linda S Geiss; Lawrence E Barker; Amanda F Elliott; John E Crews; Jinan B Saaddine Journal: Am J Ophthalmol Date: 2012-12 Impact factor: 5.258